When G6PD and ME1 are downregulated in cancer cells, adaptive upregulation of MTHFD1 (57), mitochondrial IDH2 (58), may serve to replenish the NADPH pool and mitigate cytosolic ROS. This evidence concerns the gene IDH2 and cancer.